For meetings and deliveries:
12 Veterans Square
1st Floor Left
Media, PA 19063 U.S.A.
P.O. Box 209
Swarthmore, PA 19081-0209 U.S.A.
Phone: (610) 892-9942
Twitter: @TechLaw_Elman and @ElmanTechNews
eFax: (925) 226-4995
- Selected Developments in Biotechnology Law and the Biotechnology Industry
- Informed Consent and Ethical Review in Chinese Human Experimentation: Reflections on the “Golden Rice Event”
- Q&A Session with Dr. Andrew W. Torrance of the University of Kansas School of Law: On the Question: Is Copyright the Way to Gain Intellectual Property Protection for DNA Sequences?
On May 30, 2012, the Court of Appeals for the Federal Circuit (“CAFC”) put further gloss on the term “common sense” as used by the Supreme Court in the 2007 case of KSR v. Teleflex.
This new case (Mintz v. Dietz & Watson) involved a patent on casings for hot dogs with a woven mesh pattern. The CAFC opinion criticized the district court for finding the patent claim to have been obvious, under the “common sense” rubric. The CAFC explained that “common sense” is a “shorthand label for knowledge so basic that it certainly lies within the skill set of an ordinary artisan.”
- Oct. 20, 2014 – Meet Steve Zeman and get tips about European Patent Office practice
- Supreme Court, snowed by ACLU smear campaign, resurrects archaic requirement of “invention” as a test of patent eligibility.
- State of Vermont Declares War on “Patent Trolls”
- Are Human Genes Patentable?—The Experts Weigh In
- Spark Your Creativity: participate online in Tina Seelig’s MOOC via Stanford’s Venture Lab
- U.S. Patent Licensees Get Support Against Foreign Debtors
- U.S. House Judiciary Committee Approves Legislation Creating Civil Cause of Action Under Federal Trade Secrets Protection Act
- Super Hero Copyrights - It's Complicated Marvel Comics and Kirby Settlement Leaves Questions For Freelancers
- Questioning the Executoriness of Trademark Licenses in Integrated Agreements
- Supreme Court Denies Cert in Herb Reed: Circuits to Remain Out of Tune as to Presumption of Irreparable Harm
- Commercially Confidential Information at Risk: The European Medicines Agency Issues Disclosure Policy